Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength
Crossref DOI link: https://doi.org/10.1007/s00198-015-3308-6
Published Online: 2015-09-18
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yao, W.
Dai, W.
Jiang, L.
Lay, E. Y.-A.
Zhong, Z.
Ritchie, R. O.
Li, X.
Ke, H.
Lane, N. E.
Text and Data Mining valid from 2015-09-18